Dr. Levis on the Background and Future of Quizartinib for AML Targeted Oncology 1:37 11 years ago 131 Далее Скачать
Dr. Levis Discusses the Ideal Use of Quizartinib in FLT3-ITD AML OncLive 1:18 10 years ago 451 Далее Скачать
Dr. Levis on Quizartinib in AML Patients Without the FLT3-ITD Mutation Targeted Oncology 1:04 11 years ago 373 Далее Скачать
Dr. Levis on the Ideal Way to Use Quizartinib to Treat AML Targeted Oncology 1:28 10 years ago 184 Далее Скачать
Dr. Levis on a Phase II Trial Examining Quizartinib in AML Targeted Oncology 3:00 12 years ago 228 Далее Скачать
Dr. Levis on the Challenges of Treating FLT3-ITD AML Targeted Oncology 1:57 11 years ago 741 Далее Скачать
Potential approval of quizartinib in AML & its place in the AML treatment regimen VJHemOnc – Video Journal of Hematology & HemOnc 0:57 1 year ago 259 Далее Скачать
Insights into several sub-studies of the QuANTUM-First trial of quizartinib in FLT3-ITD+ AML VJHemOnc – Video Journal of Hematology & HemOnc 3:58 5 days ago 37 Далее Скачать
Insights into the future of AML therapy: the increasing use of targeted agents VJHemOnc – Video Journal of Hematology & HemOnc 2:26 1 year ago 257 Далее Скачать
The value of FLT3 inhibitors in AML and focus for future trial designs VJHemOnc – Video Journal of Hematology & HemOnc 1:12 1 year ago 173 Далее Скачать
QuANTUM-First: the benefit of quizartinib based on pre-transplant MRD status VJHemOnc – Video Journal of Hematology & HemOnc 1:07 1 year ago 176 Далее Скачать
Dr. Levis on Gilteritinib in Relapsed/Refractory FLT3-Mutated AML OncLive 2:28 5 years ago 1 074 Далее Скачать
Progress for gilteritinib and quizartinib for AML in the first-line setting VJHemOnc – Video Journal of Hematology & HemOnc 1:50 6 years ago 308 Далее Скачать
Tangible benefit for FLT3-ITD R/R AML on quizartinib VJHemOnc – Video Journal of Hematology & HemOnc 1:59 5 years ago 193 Далее Скачать
Quizartinib for frontline FLT3-ITD+ AML: updated results from the QuANTUM-First trial VJHemOnc – Video Journal of Hematology & HemOnc 2:35 1 year ago 534 Далее Скачать
Quizartinib provides clinical benefit in R/R FLT3-ITD AML VJHemOnc – Video Journal of Hematology & HemOnc 1:28 6 years ago 115 Далее Скачать
